Abstract
It has been demonstrated that pulmonary rehabilitation(PR)improves dyspnea, effort capacity and quality of life on patients with COPD. We aimed to compare the CVR and the quality of life based on whether the included patients are exacerbator(E)or non-exacerbator(NE), and determine if there are differences pre-and post-PR. Prospective and interventional study of two groups of 51COPD patients, followed-up in a consultation, who are included in a PR programme in order to carry it out for an 8-week. CVR pre-and post-PR was calculated by means of Framingham system, SCORE, SCORE-HDL, REGICOR and QRISK. Quality of life with SF-36, QMS, HADS, CAT. We obtained a high CVR on a global level but with no reduction after finishing the PR. We observed a tendency toward improvement on the QRISK on both phenotypes(E:QRISK pre-PR:22±14.7 and post-PR9±9.6(p 0.46)vs. NE:Pre-PR22±14.7 vs.post-PR19.1±7.7(p 0.26)). The SF-36 generic health questionnaire shows global values of improvement after the PR and more specifically on the exacerbator(E pre-PR:49.1±35.5 vs.NE post-PR 63.6±29.2(p<005). COPD specific CAT shows significant differences after completion of PR, thus influencing the improvement of the impact on the quality of life of these patients, even more on the exacerbator(9.85±4.6 vs.7.83±3.97 p<0.001). We do not find differences on the anxiety and depression between both. PR is likely to reduce the value of CVR measured by QRISK, but we would need to expand the sample to assess the benefits of PR on the other scales. PR improves the quality of life of the patients, mainly on the exacerbator which would allow a better selection of them
Footnotes
Cite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA1947.
This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.
This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).
- Copyright ©the authors 2021